Concepedia

C. Hudis

CH

Statistics

Publications

20

Citations

975

H-Index

15

Active since

1995

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

C. Hudis is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and pharmacology.

Publications per year

1995–2015

20

Publications

20

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

Medicine, Oncology, Pharmacology +16

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

C. Hudis, Andrew D. Seidman, John Crown et al. · Journal of Clinical Oncology · 1996 · 152 citations

Medicine, Oncology, Pharmacology +15

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

Vito Amoroso, Daniele Generali, Thomas A. Buchholz et al. · JNCI Monographs · 2015 · 96 citations · Full text

Medicine, Oncology, Breast Oncology +16

Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Shanu Modi, S. Sugarman, A. Stopeck et al. · Journal of Clinical Oncology · 2008 · 62 citations

Medicine, Oncology, Pharmacology +17

Survival analyses from the Women's Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome

Rowan T. Chlebowski, George L. Blackburn, M. Katherine Hoy et al. · Journal of Clinical Oncology · 2008 · 49 citations

Agriculture, Nutritional Sciences, Oncology +16

1–5 of 20